Public research preview
Christopher L. Jacobs, Representative disclosure: Axsome Therapeutics, Inc. (AXSM)
Disclosed a buy transaction in Axsome Therapeutics, Inc. (AXSM). Use this page to inspect source evidence, confidence scores, filing delay, and post-disclosure price movement before deciding whether to research the signal further.
This public page is for public-disclosure research only. It is not investment advice and does not place orders. Verify the official source before relying on any signal.
Evidence passport
Official-source context and parser confidence before any simulation or alert decision.
- Source
- House STOCK Act disclosures
- Published
- 28 Jul 2022, 00:00
- Parser confidence
- 94%
- Instrument mapping
- 95%
- Filing delay
- 42 days
Timeline
Transaction date
16 Jun 2022
Public disclosure
28 Jul 2022
Now
Tracked today
Filing delay: 42 days
Price movement
Complete coverage
- Provider
- Yahoo Finance daily close
- Fetched
- 9 Sept 2026
Most of the move happened before this disclosure became public: the stock peaked +109.8% above the transaction-date close and has since retraced -15.5% from that peak. Buying now is a pullback entry on the disclosed position, not a fresh breakout.
Stock path
AXSM from pre-transaction context through latest close.
Bought
16 Jun 2022 · 21.74 USD · Not public yet
System decision
Would have bought · Discount entry — The strategy would have bought this signal, but the entry window has closed. Simulated entry on 28 Jul 2022 at 38.54 USD. Since entry: +439.2%. Planned exit on 25 Aug 2022 after 20 trading days.
- Not public yet
- Buy window
- Window closed
- System buy
- Planned exit
- Observed transaction close
- 21.74
- Observed disclosure close
- 38.54
- Observed latest close
- 207.82
- Pre-disclosure move
- +77.3%
- Post-disclosure move
- +439.2%
- Market-adjusted move
- +416.8%
- 1w since disclosure
- +3.8%
- 1m since disclosure
- +66.7%
- 3m since disclosure
- +6.0%
- Pre-disclosure peak run-up
- +109.8%
- Retrace from peak
- -15.5%
Why Copy Window is Probably too late
Supporting factors
- Parsed buy disclosure for ordinary shares from House STOCK Act disclosures.
- Reported amount is $15,001 - $50,000.
- Post-disclosure move is calculated from Yahoo Finance daily close daily closes.
Cautions
- Yahoo Finance daily close coverage is end-of-day and should be verified against the official price source.
- Review the original source document before making any investment decision.
Source document
House STOCK Act disclosures, published 28 Jul 2022, 00:00
- Parser confidence
- 94%
- Instrument mapping
- 95%